Bozena Szygula-Jurkiewicz
Overview
Explore the profile of Bozena Szygula-Jurkiewicz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
92
Citations
280
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Szczurek-Wasilewicz W, Skrzypek M, Romuk E, Gasior M, Szygula-Jurkiewicz B
J Clin Med
. 2022 May;
11(9).
PMID: 35566693
Risk stratification is an important element of management in patients with heart failure (HF). We aimed to determine factors associated with predicting outcomes in end-stage HF patients listed for heart...
12.
Osadnik T, Frycz-Kurek A, Lejawa M, Fronczek M, Malyszek-Tumidajewicz J, Szczurek-Wasilewicz W, et al.
Kardiol Pol
. 2022 Feb;
80(4):482-484.
PMID: 35176171
No abstract available.
13.
Desperak P, Desperak A, Szygula-Jurkiewicz B, Rozentryt P, Lekston A, Gasior M
J Clin Med
. 2022 Feb;
11(3).
PMID: 35159936
Background: The aim of this study was to determine the influence of acute exposure to air pollutants on patients' profile, short- and mid-term outcomes of hospitalized patients with coronary artery...
14.
Hawranek M, Pyka L, Szygula-Jurkiewicz B, Desperak P, Szczurek W, Lekston A, et al.
Postepy Kardiol Interwencyjnej
. 2022 Feb;
17(4):349-355.
PMID: 35126549
Introduction: Cardiac allograft vasculopathy remains one of the most important factors leading to chronic cardiac allograft rejection. When revascularization is needed percutaneous coronary interventions are the method of choice. Aim:...
15.
Szygula-Jurkiewicz B, Szczurek-Wasilewicz W, Osadnik T, Frycz-Kurek A, Maciol-Skurk K, Malyszek-Tumidajewicz J, et al.
Medicina (Kaunas)
. 2022 Jan;
58(1).
PMID: 35056338
: Hypertrophic cardiomyopathy (HCM) depends on the primary impairment of sarcomeres, but it can also be associated with secondary alterations in the heart related to oxidative stress. The present study...
16.
Wojtaszczyk A, Gasior M, Szygula-Jurkiewicz B, Tajstra M
Kardiol Pol
. 2022 Jan;
80(3):339-341.
PMID: 35023568
No abstract available.
17.
Szczurek-Wasilewicz W, Gasior M, Skrzypek M, Kurkiewicz K, Szygula-Jurkiewicz B
Pol Arch Intern Med
. 2021 Nov;
132(2).
PMID: 34846111
Introduction: Heart failure (HF) is a complex syndrome involving diverse pathways and pathological processes that can manifest themselves in circulation as abnormal levels of various biomarkers. Objective: The aim of...
18.
Szygula-Jurkiewicz B, Szczurek-Wasilewicz W, Gasior M, Copik I, Malyszek-Tumidajewicz J, Skrzypek M, et al.
Antioxidants (Basel)
. 2021 Nov;
10(11).
PMID: 34829684
Left ventricular assist device (LVAD) is well established as an alternative treatment for end-stage heart failure (HF) patients. The aim of the study was to determine the prognostic value of...
19.
Szczurek-Wasilewicz W, Szygula-Jurkiewicz B, Skrzypek M, Romuk E, Gasior M
Pol Arch Intern Med
. 2021 Oct;
131(10).
PMID: 34634893
Introduction: End‑stage heart failure (HF) is a clinical condition with complex pathophysiology and poor prognosis. Objectives: This study aimed to identify factors associated with mortality during a 1.5‑year follow‑up in...
20.
Szczurek W, Gasior M, Skrzypek M, Romuk E, Szygula-Jurkiewicz B
J Clin Med
. 2020 Nov;
9(11).
PMID: 33147835
Introduction: Elevated pulmonary vascular resistance (PVR) unresponsive to vasodilator treatment is a marker of heart failure (HF) severity, and an important predictor of poor results of heart transplantation (HT). Objective:...